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Introduction
People with cystic ﬁbrosis have a genetic mutation that 
dehydrates the airway epithelium, impairing the clearance 
of airway secretions by mucociliary clearance and cough 
(Boucher 2007). This impaired clearance leads to a cycle 
of mucus obstruction, infection, and inﬂammation. The 
chronic lung infection that ensues is characterised by gradual 
progressive decline in lung function interspersed with acute 
exacerbations, and eventual respiratory failure (Ratjen 
2009). Although prognosis has improved markedly for 
people with cystic ﬁbrosis over the past few decades, cystic 
ﬁbrosis remains a life-shortening disease with respiratory 
failure still accounting for the majority of mortality (Viviani 
et al 2012). Therefore, it is important to identify and use 
interventions that target this pathogenic pathway.
Several categories of interventions are used to treat mucus 
obstruction and infection in people with cystic ﬁbrosis. 
Antibiotics are used to suppress infection (Doring et al 
2000), various mucoactive medications are used to improve 
both the patency of the airways and the physical properties 
of the mucus to aid its clearance (Heijerman et al 2009, 
Bishop et al 2011), and a range of physical techniques are 
used to dislodge mucus and to facilitate its expectoration. 
These physical techniques may include positioning, manual 
techniques, positive pressure devices, breathing techniques, 
and exercise (van der Schans et al 2000).
Although airway clearance is a widely recommended goal of 
treatment in the management of cystic ﬁbrosis lung disease 
(Flume et al 2009), people with cystic ﬁbrosis typically have 
low adherence to their airway clearance regimen despite 
being aware of its importance (Myers 2009). At various 
stages of disease progression, people with cystic ﬁbrosis may 
view airway clearance as an inconvenience. When patients 
have mild lung disease and minimal sputum production, 
an airway clearance session may be perceived as time-
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What is already known on this topic: Airway 
clearance techniques are widely recommended for 
people with cystic ﬁbrosis, but adherence with regular 
use is often poor. Exercise might be an alternative 
airway clearance method with other beneﬁts.
What this study adds: A session of various 
whole-body exercises interspersed with expiratory 
manoeuvres could be an acceptable substitute for 
a regimen of breathing and manual techniques for 
airway clearance in children with cystic ﬁbrosis. 
The effect on sputum clearance is similar, while the 
immediate effects on lung function and treatment 
satisfaction are greater.
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consuming and ineffective, or useless. In the more severe 
stages of the disease, an increase in the duration of airway 
clearance sessions may be appropriate. However, when 
airway clearance is prolonged, motivation and adherence 
may decrease. Also, some airway clearance techniques are 
not well tolerated clinically. Therefore, it is important to 
compare the effects of the various physical interventions 
for airway clearance, considering their relative effects on 
sputum clearance, lung function, and patient satisfaction.
Exercise offers some potential advantages over other 
physical airway clearance interventions (van Doorn 2010). 
In addition to enhancing mucus clearance (Salh et al 1989, 
Bilton et al 1992), it improves cardiorespiratory ﬁtness 
(van Doorn 2010), muscle mass, strength, and body image 
(Sahlberg et al 2008), as well as emotional wellbeing and 
perceived health (Selvadurai et al 2002, Hebestreit et al 
2010). Perhaps most importantly, a recent systematic review 
examining trials of exercise in children with cystic ﬁbrosis 
concluded that a long-term exercise program may protect 
against pulmonary function decline (van Doorn 2010). 
Furthermore, exercise is often more readily accepted by 
patients, especially the youngest (Moorcroft et al 1998, 
McIlwaine 2007), than other airway clearance methods 
(Bilton et al 1992). This may be because it is a more ‘normal’ 
activity and because it can be tailored for greater enjoyment 
(Kuys et al 2011).
Although substantial evidence shows that exercise is 
better than no exercise, fewer trials have been conducted 
to evaluate the usefulness of acute exercise as a substitute 
for or assistance in airway clearance. Most of these trials 
have studied adults (Bilton et al 1992, Baldwin et al 1994, 
Salh et al 1989, Lannefors & Wollmer 1992) with fewer 
studying children (Zach et al 1981, Zach et al 1982, Cerny 
1989). However, the trials by Zach and colleagues were not 
randomised and the trial by Cerny examined the effect of 
substituting exercise for two of three sessions per day of 
manual airway clearance techniques in postural drainage 
positions. These features make it difﬁcult to compare the 
effects of exercise to those of breathing/manual techniques 
for airway clearance. Therefore, we sought to compare 
the effect on airway clearance of exercise and chest 
physiotherapy in children with stable cystic ﬁbrosis lung 
disease. The research questions for this study were:
1. Can a session of exercise with incorporated expiratory 
manoeuvres substitute for a session of breathing 
techniques for airway clearance in children with cystic 
ﬁbrosis?
2. Are children with cystic ﬁbrosis as co-operative 
and satisﬁed with the exercise regimen as with the 
breathing techniques?
Method
Design
A randomised cross-over trial with concealed allocation 
and intention-to-treat analysis was conducted at the Lyon 
Paediatric Cystic Fibrosis Centre in France to compare a 
regimen of exercise combined with expiratory manoeuvres 
against a control regimen of breathing techniques. Each 
intervention was tested once on non-consecutive days 
scheduled to coincide with quarterly clinic appointments. 
Each intervention lasted 20 minutes. Between the two 
interventions, patients continued their usual treatments and 
airway clearance techniques.
Participants, therapists, centres
Participants were recruited from the Paediatric Cystic 
Fibrosis Centre between March and December 2006. 
Children attending the clinic were eligible to participate 
if they were aged 7–18 years; had a conﬁrmed diagnosis 
of CF (two positive sweat tests and/or two cystic ﬁbrosis 
transmembrane conductance regulator gene mutations 
with compatible clinical signs), regardless of their basal 
pulmonary function status; were clinically stable; and 
were able to expectorate and understand the protocol 
instructions. Patients were deemed stable when they had no 
signs of pulmonary exacerbation as deﬁned by Rosenfeld 
and colleagues (2001), together with a predicted forced 
expiratory volume in 1 s (FEV1) that was not below 10% of 
the mean FEV1 calculated with the four previous values of 
the year. Patients with pulmonary exacerbation or deemed 
clinically unstable were adequately treated and invited to 
participate later, whenever possible. Exclusion criteria were 
haemoptysis greater than 50 mL in one day and permanent 
non-invasive ventilation.
After eligibility was conﬁrmed, one investigator (BK) at 
the Clinical Investigation Centre used a computer-generated 
randomisation list to allocate participants to commence 
the study protocol beginning with either the exercise with 
expiratory manoeuvres (experimental) intervention or the 
breathing techniques (control) intervention. Participants 
started their ﬁrst session of the study at the next scheduled 
quarterly clinic appointment to avoid making additional visits.
Intervention
Experimental intervention: The experimental intervention 
consisted of three periods of exercise each lasting 5 min, 
supervised by a physiotherapist (FA). The ﬁrst period 
consisted of 2 min of indoor jogging, 1 min of stair climbing 
(three ﬂoors), and 2 min of cycling on an ergometer. 
Resistance on the ergometer was adjusted to ensure that 
the participant’s respiratory rate was elevated during the 2 
min of cycling. At the end of the ﬁrst period, the patient 
performed several prolonged and brief expiratory ﬂow 
accelerations with open glottis, the forced expiratory 
technique, and ﬁnally cough and sputum expectoration. 
These clearance manoeuvres were performed over 1.5 min. 
The second period consisted of 1 min of stretching repeated 
ﬁve times, followed by the same expiratory manoeuvres 
for 1.5 min, as described above. The third period consisted 
of continuous jumping on a small trampoline. It included 
2 min of jumping, 2 min of jumping while throwing and 
catching a ball, and 1 min of jumping while hitting a tossed 
ball. This was again followed by expiratory manoeuvres for 
1.5 min. The entire regimen was followed by 40 min rest.
Control intervention: The control intervention consisted 
of a regimen of breathing and manual techniques usually 
prescribed by physiotherapists in our centre to promote 
airway clearance. Initially, participants instilled a small 
amount (~2.5 mL) of normal saline into each nostril and blew 
their nose, to facilitate nasal airﬂow during the intervention. 
The intervention then consisted of three steps modelled 
on the active cycle of breathing technique: breathing 
control, thoracic expansion, and forced expiration. Initially, 
participants were positioned in supported long sitting with 
the trunk inclined at 30 degrees and commenced quiet 
breathing around tidal volume. They were then encouraged 
to increase the diaphragmatic component to inspiration 
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by achieving expansion of the abdomen and lower chest 
while relaxing the upper chest and shoulders. This was 
continued for 1.5 min. Participants then commenced deeper 
inspirations (towards total lung capacity) without inspiratory 
pauses. With this increasing use of the inspiratory reserve 
volume, participants were still encouraged to use lower 
chest expansion. This was also continued for 1.5 min. Next, 
in order to facilitate the movement of secretions to the 
proximal airways, prolonged forced expiratory ﬂows were 
performed, accompanied by anterolateral thoracic manual 
compression by the physiotherapist at the end of expiration, 
and ﬁnally hufﬁng (usually two) and/or coughing when 
secretions had reached the proximal airways. Typically, 
participants sat up at the end of the forced expiratory 
manoeuvre to cough and expectorate. This typically took 1 
min. Therefore, one completion of the breathing techniques 
usually lasted ~5 min, and this was completed four times. 
The entire regimen was followed by 40 min rest.
Outcome measures
Primary outcome: The wet weight of expectorated sputum was 
the primary outcome measure. The sputum produced by all 
phases of each intervention and during the 40-min rest period 
that followed was collected in a sterile container and weighed. 
Participants were strongly encouraged not to swallow any 
secretions cleared from the lungs and to place all expectorated 
material in the container during the collection period.
Secondary outcomes: Lung function was measured using 
spirometry according to American Thoracic Society 
standards (Miller et al 2005). FEV1 was measured using 
a calibrated spirometera. Pre- and post-bronchodilator 
spirometry was performed on each day immediately before 
the intervention was commenced. The bronchodilator was 
200 to 400 μg of salbutamol, according to each participant’s 
usual dose and kept consistent between study days, via a 
spacer deviceb. The best FEV1 value obtained (either before 
or after bronchodilators) was kept for analysis. Spirometry 
was repeated 10–30 min after the 40-minute rest period. 
FEV1 was expressed as a percentage of the predicted values 
for the participant’s height and gender (Bellon et al 1982). 
In addition to the analysis of the data when expressed as a 
percentage of predicted values, change in FEV1 was also 
analysed in relative percent, ie,
(FEV1 end − FEV1 start) * 100 / FEV1 start
Participant co-operation with each intervention was rated 
by the treating physiotherapist. Ratings were recorded on a 
Likert-type scale from 1 (participant refused to co-operate 
with the intervention) to 5 (excellent co-operation).
The quality of each intervention was rated by the participant. 
Ratings were recorded on a Likert-type scale from 1 (poor) 
to 5 (excellent). The ratings of treatment quality were made 
at the end of the 40-min rest period for each intervention.
Participant satisfaction with each intervention was rated by 
participants on a visual analogue scale from 0 (not satisﬁed 
at all) to 100 (fully satisﬁed). The ratings of satisfaction were 
made at the end of the 40-min rest period for each intervention.
Any adverse changes in a participant’s clinical status were 
noted as an adverse event. Non-invasive pulse oximetry 
was used throughout each intervention to monitor for 
oxyhaemoglobin desaturation.
Data analysis
We calculated the sample size based on the primary outcome. 
For the smallest worthwhile effect of one intervention versus 
another, we nominated a 1.5 g difference in the wet weight 
of expectorated sputum produced. We anticipated a standard 
deviation of the difference between the two values for the 
same patient at 2.8 g, based on data reported by Bilton et al 
(1992). With an alpha risk of 5% and a study power of 80%, 
a total of 30 patients were required. To allow for 10% loss 
to follow-up, this sample was increased to 34 participants.
The characteristics of the participants were described using 
means and standard deviations for continuous variables and 
using numbers and percentages for categorical variables. 
An analysis of variance, which took period and sequence 
effects into account, was used to estimate the effect of the 
intervention on sputum weight and FEV1. In the absence of 
period and sequence effects, a paired t-test was calculated. 
Co-operation and perceived treatment quality were 
analysed as the relative risk of a rating of good to excellent. 
Adverse events were also analysed using relative risk. A 
mixed-effect Tobit model was used to analyse the effect of 
the intervention on satisfaction while taking a ceiling effect 
into account.
Results
Flow of participants through the study
Fifty-ﬁve patients were assessed for eligibility, of whom 34 
underwent randomisation (Figure 1). Among the 10 patients 
who refused to participate, 4 stated that they did not enjoy 
sport and 6 stated that they did not like spirometry. The 
baseline characteristics of the participants who completed 
the study are presented in Table 1. The two groups of 
participants were comparable at the start of the intervention 
arms in terms of pulmonary function, nutritional status and 
therapeutic requirements (Table 2 and the ﬁrst two columns 
of data in Table 3). There was also no statistically signiﬁcant 
difference in FEV1 values between the start of the ﬁrst and 
second intervention arms (p = 0.6).
Compliance with the trial method
All randomised participants completed their ﬁrst allocated 
intervention. One participant was withdrawn before 
undertaking the control intervention due to unstable 
lung disease and one participant was withdrawn before 
undertaking the experimental intervention for psychological 
reasons. The second intervention arm occurred at the 
next scheduled quarterly visit for 18 participants. For the 
remaining participants, because of unavailability or clinical 
instability, the second session was done at 5 months for one 
patient, 6 months for ten patients, and at 9, 10 and 14 months 
for one participant each.
Effect of intervention
Primary outcome: The wet weight of expectorated sputum 
was slightly higher after the experimental intervention than 
after the control intervention, but the mean difference of 
0.6 g (95% CI –0.2 to 1.4) was not statistically signiﬁcant in 
the analysis, which took into account sequence and period 
effects (Table 4). Individual data are presented in Table 5 
(see eAddenda for Table 5).
Secondary outcomes: On average, FEV1 as a percentage of 
the predicted value improved by 2% after the experimental 
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5BCMF. Baseline characteristics of study completers.
Characteristic n = 32
Age (yr), mean (SD) 12 (3)
Gender, n male (%) 18 (56)
Genotype, n (%)
 F508del homozygote 13 (41)
 F508del heterozygote 17 (53)
 other 2 (6)
Height (cm), mean (SD) 146 (14)
Weight (kg), mean (SD) 36 (11)
Long-term medication use, n (%)
 rhDNase 26 (81)
 Hypertonic saline 0 (0)
 Colimycin 14 (44)
 Tobramycin 1 (3)
 Azithromycin 14 (44)
Chronic Pseudomonas aeruginosa 
airway colonisation
15 (47)
'JHVSF Design and ﬂow of participants through the trial.
Experimental Intervention
t Exercise
t Forced expiratory technique
Control Intervention
Control Intervention
t Breathing control
t Thoracic expansion with 
manual compressions
t Forced expiratory technique
Experimental Intervention
Clinic outpatients screened for eligibility (n = 55)
Measured spirometry 
Randomised (n = 34)
(n = 18)                                                                                                      (n = 16)
Excluded (n = 21)
t respiratory exacerbation at ﬁrst visit (n = 4)
t refused (n = 10)
t accepted after enrolment period (n = 7)
Measured sputum weight, spirometry, cooperation, perceived  
treatment quality, satisfaction and adverse events
(n = 18)                                                                                                      (n = 16)
Measured spirometry
(n = 17)                                                                                                      (n = 15)
Measured sputum weight, spirometry, cooperation, perceived  
treatment quality, satisfaction and adverse events
(n = 17)                                                                                                      (n = 15)
Withdrawn (n = 1) Withdrawn (n = 1)
5BCMF. Characteristics of study completers at entry to 
the ﬁrst intervention arm by randomly allocated group.
Characteristic Exp ﬁrst 
(n = 17)
Con ﬁrst 
(n = 15)
#.*	LHNã
NFBO	4%
 16.5 (2.0) 16.5 (1.7)
Therapy use, n (%)
 rhDNase use 11 (65) 12 (80)
 antibiotic use 8 (47) 7 (47)
"JSXBZDMFBSBODFTFTTJPOTXL
mean (SD)
4.7 (1.7) 4.2 (1.4)
Exp = experimental intervention, Con = control intervention, 
BMI = body mass index.
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intervention and deteriorated by 1% after the control 
intervention (Table 3). Individual data are presented in 
Table 5 (see eAddenda for Table 5). The mean difference 
just reached statistical signiﬁcance at 3% (95% CI 0 to 6). 
In relative terms, FEV1 improved with the experimental 
intervention by 2.7% (SD 6.8%) and deteriorated with the 
control intervention by 0.5 (SD 6.0%), which equated to a 
statistically signiﬁcant mean difference of 3.2% (95% CI 
0.5 to 6.0).
After the experimental intervention, co-operation was rated 
as excellent or good for 30 (94%) of the 32 completing 
participants and poor for two (6%) participants. The results 
were similar after the control intervention with co-operation 
rated as excellent or good for 31 (97%) of participants and 
poor for one (3%). This difference was not statistically 
signiﬁcant (RR = 1.03, 95% CI 0.93 to 1.15).
The quality of the experimental intervention was rated 
as excellent or good by 27 (84%) of the 32 completing 
participants. The quality of the control intervention 
was rated as excellent or good by 30 (94%) participants. 
No participants rated either intervention as poor. This 
difference was again not statistically signiﬁcant (RR = 1.11, 
95% CI 0.93 to 1.32).
The mean satisfaction score was 89 (SD 16) after the 
experimental intervention and at 72 (SD 27) after chest 
physiotherapy (Table 4). The result of the Tobit model, 
taking into account period and sequence effects, estimated 
a mean between-group difference of 24, which was 
statistically signiﬁcant (95% CI 10 to 38). A period effect 
5BCMFMean (SD) for outcomes at the end of the intervention period,  
and mean (95% CI) difference between interventions.
Interventions Difference between interventions
Exp 
(n = 32)
Con 
(n = 32)
Exp minus Con
Sputum weight 
(g)
3.7 
(3.5)
3.2 
(3.1)
0.6a 
(–0.2 to 1.4)
Patient satisfaction 
(0 to 100)
89 
(16)
72 
(27)
24b 
(10 to 38)
Shaded row = primary outcome, Exp = experimental intervention, Con = control intervention.  
a adjusted ANOVA, b adjusted Tobit model
was also identiﬁed with a greater satisfaction score after 
the ﬁrst period than after the second period. The difference 
in mean score between the two periods was estimated at 
19 (95% CI 5 to 32). In a post hoc subgroup analysis, the 
difference in the mean satisfaction score between the two 
interventions was greater in children aged 12 years or less 
than in children over 12 years old. The difference was 35 
(95% CI 15 to 55) in favour of the experimental intervention 
among the younger children and 9 (95% CI –6 to 24) in 
favour of the experimental intervention among the older 
children.
Four participants experienced adverse events during the 
experimental intervention and one participant experienced 
adverse events during the control intervention, which was 
not statistically signiﬁcant (RR = 4.00, 95% CI 0.47 to 
33.86). The adverse events were fatigue, breathlessness, 
and oxygen desaturation below 92%, all of which required 
interruption of the intervention but resolved swiftly.
Discussion
This randomised trial conducted in children with cystic 
ﬁbrosis compared an exercise regimen with expiratory 
manoeuvres against a regimen of breathing and manual 
techniques for airway clearance. The primary outcome 
did not show signiﬁcantly greater wet weight of sputum 
expectorated with one intervention or the other. However, 
the estimate of the mean difference had a conﬁdence interval 
of –0.2 g to 1.4 g, which is sufﬁciently precise to exclude the 
nominated smallest worthwhile effect of 1.5 g. Therefore 
we can conclude that the effects of the two interventions on 
5BCMF Mean (SD) for outcomes for each group, mean (SD) difference within groups, and mean (95% CI) difference 
between groups.
Interventions Difference within  
interventions
Difference between  
interventions
Pre Post Post minus Pre Post minus Pre
Exp 
(n = 32)
Con 
(n = 32)
Exp 
(n = 32)
Con 
(n = 32)
Exp Con Exp minus Con
FEV1 
(% pred)
93 
(14)
94 
(14)
96 
(15)
94 
(14)
2 
(6)
–1 
(6)
3 
(0 to 6)
FEV1 
(relative %)
2.7 
(6.8)
–0.5 
(6.0)
3.2 a 
(0.5 to 6.0)
Exp = experimental intervention, Con = control intervention, FEV1 = forced expiratory volume in one second. a adjusted ANOVA
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sputum expectoration do not differ to a clinically important 
extent. This is an important ﬁnding because it indicates that 
one intervention or the other may be chosen based on, eg, 
its effects on other outcomes or acceptability to the child 
with cystic ﬁbrosis.
In the analyses of lung function in this study, exercise 
tended to have the better effect of the two interventions. 
Although no smallest worthwhile effect was nominated 
for FEV1, the lower limit of the conﬁdence interval was 
clearly clinically trivial, while the upper limit is arguably 
a clinically worthwhile difference to achieve with a single 
application of the intervention. This suggests that children 
who prefer to achieve airway clearance through exercise 
would not do so at the expense of their lung function. This 
result is consistent with the study by Bilton et al (1992), in 
which FEV1 improved within 20 min of exercise. However, 
an important caveat here is that the long-term effects of 
these interventions may not be a simple extrapolation of 
their effects after a single treatment. Nevertheless, if the 
effect does persist, this may explain how short-term training 
programs increase pulmonary function (Selvadurai et al 
2002) and long-term programs protect against lung function 
decline (Schneiderman-Walker et al 2000).
The acceptability of an airway clearance intervention to 
children with cystic ﬁbrosis is an important consideration 
because they are recommended to perform airway 
clearance regularly on an ongoing basis (Lester et al 2009, 
Schechter 2007). If adherence is to be maintained with 
this indeﬁnite prescription to perform airway clearance, 
the acceptability of the clearance regimen is crucial. 
Therefore, another important ﬁnding of the study was that 
the secondary outcomes that reﬂect acceptability were also 
similar between the interventions as well. The perceived 
quality of both interventions and the child’s co-operation 
with them was good or excellent for almost all participants, 
with no important differences between the interventions. 
Satisfaction scores were also high for both interventions, 
although notably satisfaction with the exercise intervention 
was signiﬁcantly higher, especially among the children 
younger than 12 years. The higher satisfaction scores 
corroborate our and others’ experience that people with 
cystic ﬁbrosis get frustrated with conventional airway 
clearance techniques and prefer exercise or a combination 
of both interventions (Moorcroft et al 1998, Bilton et al 
1992, Baldwin et al 1994). The fact that satisfaction is 
greater after one treatment is promising for exercise, given 
that there are many ways it can be modiﬁed to keep it novel, 
enjoyable, and challenging while maintaining a suitable 
exercise load (Kuys et al 2011).
Two more caveats are worth noting here. Some other 
exercise modalities may not have the same airway clearance 
effects and any exercise modality may not be effective 
without the incorporation of the short bouts of expiratory 
manoeuvres. Therefore extrapolation of these results should 
be done with caution until further assessment of the airway 
clearance effects of other exercise regimens is available.
As well as being a satisfying alternative to traditional airway 
clearance techniques, the exercise regimen we examined 
appears to be a safe alternative. Adverse events were few, 
mild and transient.
Our results indicate that the participants had relatively 
low quantities of sputum to expectorate compared to adult 
studies, which report higher sputum production, eg, 10 to 20 
g over periods of 50 to 150 min (Bilton et al 1992, Baldwin 
et al 1994, Salh et al 1989). The smaller amount of sputum in 
our participants is likely to be due to their mild lung disease. 
Given our efforts to ensure expectoration, we do not think 
that the small amount of sputum indicates that sputum was 
swallowed. However, this is a theoretical source of bias that 
must be considered. The vigour of the exercise intervention 
may have entailed a higher risk of accidental or unnoticed 
swallowing of secretions than the control intervention. 
However, if such bias did occur, this would only further 
support our conclusion that the exercise intervention was a 
suitable substitute for the control intervention in this study.
The conclusions of our study are limited because each 
intervention was only applied once for 20 min, and in a 
hospital environment, where treatment co-operation and 
quality may surpass that achieved at home. Also, although 
eligibility was not restricted to a speciﬁc FEV1 range, most 
of the children had excellent lung function so the results 
may not apply to more severely affected children. Another 
limitation of the study was the long period between the two 
interventions, although the patients’ clinical status appeared 
to remain comparable at the start of the two study arms.
This study showed that several bouts of different exercises 
interspersed with expiratory manoeuvres could be an 
acceptable substitute for a regimen of breathing and manual 
techniques for airway clearance in children with mild cystic 
ﬁbrosis lung disease. In the setting of a chronic paediatric 
lung disease with a high burden of care and poor adherence 
to therapy, especially for airway clearance and aerosol 
therapy, this subset of patients could sometimes perform 
these exercises as their airway clearance regimen without 
detriment to their lung function. Q
Footnotes: aMasterscreen PFT, Jaeger, Hoechberg, 
Germany. bAerochamber, Boehringer Ingelheim Ltd, 
Bracknell, UK
eAddenda: Table 5 available at jop.physiotherapy.asn.au.
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